Coya Therapeutics, Inc. (COYA) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 5 Buy.
The consensus price target is $17.00, representing an upside of 281.2% from the current price $4.46.
Analysts estimate Earnings Per Share (EPS) of $-1.10 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.98 vs est $-1.09 (beat +10.5%). 2025: actual $-1.27 vs est $-1.19 (missed -6.4%). Analyst accuracy: 91%.
COYA Stock — 12-Month Price Forecast
$17.00
▲ +281.17% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Coya Therapeutics, Inc., the price target is $17.00.
The average price target represents a +281.17% change from the last price of $4.46.
COYA Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Coya Therapeutics, Inc. in the past 3 months
EPS Estimates — COYA
91%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.98
vs Est –$1.09
▲ 11.7% off
2025
Actual –$1.27
vs Est –$1.19
▼ 6.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — COYA
86%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.004B
vs Est $0.004B
▼ 3.2% off
2025
Actual $0.008B
vs Est $0.006B
▲ 25.5% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
